|
FDA Microbiology Devices Panel of the Medical Devices Advisory Committee
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIAID
|
This Committee provides expertise in the evaluation of evidence submitted by pharmaceutical companies to the Food and Drug Administration (FDA) for drug approval.
|
|
FDA Substance Registry System Public Interface
|
Resource Development
|
FDA
|
NLM
|
The National Library of Medicine (NLM) and the Food and Drug Administration (FDA) established a collaborative effort to provide an interface for public access to the FDA’s Substance Registration System (SRS). The FDA SRS utilizes an existing NLM database backend architecture to provide public search capability for FDA substances and medicinal products.
|
|
FDA Uterine Fibroids Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NICHD, OD/DPCPSI/ORWH
|
The Uterine Fibroids Working Group is one working group of the Women’s Health Clinical Research Network (WH-CRN) that focuses specifically on the treatment of fibroids. The WH-CRN seeks to meet the growing demand for evidence that better reflects the patient experience during routine care by creating a coordinated registry network (CRN) that uses structured data capture and HL7 FHIR to efficiently extract, standardize, and exchange data from electronic health records and link registries and other data sources to cover a number of technologies in clinical areas unique to women.
|
|
FDA-NCI Quarterly Meeting
|
Meeting/ Workshop
|
FDA
|
NCI
|
This Quartely meeting to enhance communication between the National Cancer Institute (NCI) and the Food and Drug Administration (FDA), thereby expediting the development of new anti-cancer agents. General topics discussed include patient safety, clinical efficacy, and regulatory pathways to licensure, as well as an understanding of the operations of the sister agencies.
|
|
FDA/NIH Interagency Clinical Outcomes Assessments Working Group Meeting
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIMH, NCCIH, NCI, NHLBI, NIAMS, NINDS
|
The Food and Drug Administration (FDA) and Institute representatives from the National Institutes of Health (NIH) meet periodically to discuss the development of valid patient-oriented treatment outcomes, and relative measurements, for use in clinical trials of therapeutic interventions.
|
|
Federal Breastfeeding Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS
|
NICHD, NCI, NHLBI, NIDDK
|
The purpose of this workgroup is to develop strategies to implement the Surgeon General’s call to action to support breastfeeding.
|
|
Federal Consortium on the Substance Abusing Offender
|
Committee, Work group, Advisory group, or Task Force
|
SAMHSA
|
NIDA
|
Coordination of approximately a dozen agencies that work with substance abusing offenders. Staff meet by phone quarterly to provide updates on projects and initiatives at their agencies at the intersection of substance use and justice.
|
|
Federal Dietary Reference Intakes Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, OS
|
NIDDK, NHLBI, OD/DPCPSI/ODS
|
This Dietary Reference Intakes subcommittee reports to the Interagency Committee on Human Nutrition Research (ICHRN) to provide oversight on the process used to establish the Dietary Reference Intakes. These values serve as a basis for many federal nutrition programs and policies.
|
|
Federal Education and Training Interdisciplinary Group (FETIG). National Center for Disaster Medicine and Public Health
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NICHD
|
The Federal Education and Training Interagency Group for Public Health and Medical Disaster Preparedness and Response (FETIG) committee provides oversight and guidance to the National Center for Disaster Medicine and Public Health, which is a center of the Uniformed Services University of the Health Sciences.
|
|
Federal Experts Security Advisory Panel (FESAP)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
OD/OSP, NIAID
|
Provides recommendations related to the security of biological select agents and toxins (BSAT) to the Secretaries of Health and Human Services and Agriculture and the Attorney General.
|